Abstract:Abstract Background Microglia are key regulators of the inflammatory response in the brain. Adenosine in RNAs can be converted to m 6 A (N 6 -methyladenosine), which regulates RNA metabolism and functions as a key epitranscriptomic modification. The m 6 A modification pattern and m 6 A-related signatures under pro-inflammatory and anti-inflammatory conditions of microglia remain unclear. Methods Primary rat microglia were differentiated into pro-inflammatory M1-like (M1-L), anti-inflammatory M2-like (M2-L), and resting, unstimulated (M0-L) phenotypes. m 6 A mRNA and lncRNA epitranscriptomic microarray analyses were performed, and pathway analysis was conducted to understand the functional implications of m 6 A methylation in mRNAs and lncRNAs. The m 6 A methylation level and gene expression of mRNAs and lncRNAs were subsequently verified by m 6 A Me-RIP and qRT-PCR. Results A total of 1588 mRNAs and 340 lncRNAs, 315 mRNAs and 38 lncRNAs, and 521 mRNAs and 244 lncRNAs were differentially m 6 A methylated between M1-L and M0-L (M1-L/M0-L), M2-L and M0-L (M2-L/M0-L), M2-L and M1-L (M2-L/M1-L), respectively. Furthermore, 4902 mRNAs, 4676 mRNAs, and 5095 mRNAs were identified distinctively expressed in M1-L/M0-L, M2-L/M0-L, and M2-L/M1-L, respectively. Pathway analysis of differentially m 6 A methylated mRNAs and lncRNAs in M1-L/M0-L identified immune system, signal transduction, and protein degradation processes. In contrast, the distinct m 6 A methylated mRNAs in M2-L/M0-L were involved in genetic information processing, metabolism, cellular processes, and neurodegenerative disease-related pathways. We validated m 6 A methylation and the expression levels of five mRNAs and five lncRNAs, which were involved in upregulated pathways in M1-L/M0-L, and five mRNAs involved in upregulated pathways in M2-L/M0-L. Conclusions These findings identify a distinct m 6 A epitranscriptome in microglia, and which may serve as novel and useful regulator during pro-inflammatory and anti-inflammatory response of microglia.

N6-methyladenosine in myeloid cells: a novel regulatory factor for inflammation-related diseases

N6-Methyladenosine (m6A) Modification in Natural Immune Cell-Mediated Inflammatory Diseases

The emerging roles of N6-methyladenosine RNA methylation in human cancers

N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

The Emerging Molecular Mechanism of M6a Modulators in Tumorigenesis and Cancer Progression

Potential Roles of N6-methyladenosine (m6a) in Immune Cells

Exploring the impact of m6A modification on immune diseases: mechanisms and therapeutic implication

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Physio-pathological Effects of N6-methyladenosine and Its Therapeutic Implications in Leukemia

Emerging role of N6-methyladenosine RNA methylation in lung diseases

Regulatory roles of N6-methyladenosine (m 6 A) methylation in RNA processing and non-communicable diseases

The potential roles of m6A modification in regulating the inflammatory response in microglia

Regulatory Roles of N6-methyladenosine (m6a) Methylation in RNA Processing and Non-Communicable Diseases

N6-methyladenosine and its epitranscriptomic effects on hematopoietic stem cell regulation and leukemogenesis

Progress on N~6-methyladenosine Regulation of Immune Homeostasis Chinese Full Text English Full Text (MT)

The Emerging Clinical Application of m6A RNA Modification in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

N6-methyladenosine and Neurological Diseases

N 6 ‐methyladenosine Steers RNA Metabolism and Regulation in Cancer

Regulation of m6Am RNA modification and its implications in human diseases

Progress on &Amp;lt;italic&gt;n&lt;/italic&gt;&lt;sup&gt;6&lt;/sup&gt;-Methyladenosine Regulation of Immune Homeostasis